Literature DB >> 7650113

Sperm retrieval methods and ICSI for obstructive azoospermia.

M Tsirigotis1, I Craft.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7650113     DOI： 10.1093/oxfordjournals.humrep.a136030

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  6 in total

1.  Successful percutaneous epididymal sperm aspiration (PESA) after more than 20 years of acquired obstructive azoospermia.

Authors:  G I Meniru; M Tsirigotis; J Zhu; I Craft
Journal:  J Assist Reprod Genet       Date:  1996-05       Impact factor: 3.412

2.  Is diagnostic testicular fine needle aspiration necessary in azoospermic men before sperm aspiration/extraction for intracytoplasmic sperm injection cycles?

Authors:  Z Zukerman; R Orvieto; O M Avrech; D B Weiss; S Gottschalk-Sabag; E Bar-On; O Rufas; I Bar-Hava; Z Ben-Rafael; B Fisch
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

3.  Cumulative experience of percutaneous epididymal sperm aspiration (PESA) with intracytoplasmic sperm injection.

Authors:  M Tsirigotis; M Pelekanos; S Beski; S Gregorakis; C Foster; I L Craft
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

4.  Embryo developmental stage at transfer influences outcome of treatment with intracytoplasmic sperm injection.

Authors:  J Zhu; G I Meniru; I L Craft
Journal:  J Assist Reprod Genet       Date:  1997-05       Impact factor: 3.412

5.  Significance of serum FSH levels and testicular morphology in infertile males.

Authors:  O Yaman; E Ozdiler; I Seçkiner; O Göğüş
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 6.  Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update.

Authors:  Rossella Mazzilli; Alberto Vaiarelli; Lisa Dovere; Danilo Cimadomo; Nicolò Ubaldi; Susanna Ferrero; Laura Rienzi; Francesco Lombardo; Andrea Lenzi; Herman Tournaye; Filippo Maria Ubaldi
Journal:  Asian J Androl       Date:  2022 Mar-Apr       Impact factor: 3.285
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.